| NAME |
CERTOLIZUMAB PEGOL 200MG/ML INJ,SOLN SYR,2ML |
| VA GENERIC NAME |
CERTOLIZUMAB |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Certolizumab_(Cimzia)_(2019).pdf |
| FORMULARY DESIGNATOR |
PA-F |
| FORMULARY DESIGNATOR TEXT |
Restricted to providers appropriate for prescribing TNF inhibitors
|
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
YES |
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
200 |
| INACTIVATION DATE |
2009-09-16 00:00:00 |
| UNITS |
MG/ML |
| NATIONAL FORMULARY NAME |
CERTOLIZUMAB INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
CERTOLIZUMAB PEGOL 200MG/ML INJ SYR 2ML |
| VA PRODUCT IDENTIFIER |
C1379 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
SYR |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4028772 |
| EFFECTIVE DATE/TIME |
-
- 2009-07-09 00:00:00
- STATUS: ACTIVE
-
- 2009-09-16 00:00:00
- STATUS: INACTIVE
|